IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 165 filers reported holding IMPAX LABORATORIES INC in Q4 2013. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $79,298,000 | -48.1% | 5,984,758 | -7.2% | 0.02% | -51.6% |
Q3 2016 | $152,784,000 | -8.6% | 6,446,579 | +11.2% | 0.03% | -16.2% |
Q2 2016 | $167,079,000 | -7.0% | 5,797,323 | +3.3% | 0.04% | -11.9% |
Q1 2016 | $179,699,000 | -23.4% | 5,612,082 | +2.3% | 0.04% | -22.2% |
Q4 2015 | $234,499,000 | +18.9% | 5,484,063 | -2.1% | 0.05% | +5.9% |
Q3 2015 | $197,237,000 | -20.2% | 5,601,733 | +4.1% | 0.05% | -13.6% |
Q2 2015 | $247,076,000 | -0.7% | 5,380,576 | +1.4% | 0.06% | 0.0% |
Q1 2015 | $248,767,000 | +56.5% | 5,307,590 | +5.8% | 0.06% | +51.3% |
Q4 2014 | $158,964,000 | +42.7% | 5,017,796 | +6.8% | 0.04% | +25.8% |
Q3 2014 | $111,400,000 | -20.7% | 4,698,460 | +0.3% | 0.03% | -22.5% |
Q2 2014 | $140,416,000 | +7.4% | 4,682,088 | -5.4% | 0.04% | +2.6% |
Q1 2014 | $130,708,000 | +8.6% | 4,947,295 | +3.4% | 0.04% | +5.4% |
Q4 2013 | $120,310,000 | +28.0% | 4,785,586 | +4.3% | 0.04% | +15.6% |
Q3 2013 | $93,956,000 | +13.5% | 4,589,944 | +10.5% | 0.03% | +6.7% |
Q2 2013 | $82,786,000 | – | 4,152,160 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 560,400 | $9,022,000 | 3.93% |
NORTH TIDE CAPITAL, LLC | 1,000,000 | $16,100,000 | 3.58% |
Sivik Global Healthcare LLC | 250,000 | $4,025,000 | 1.47% |
MAVERICK CAPITAL LTD | 7,159,336 | $115,265,000 | 1.44% |
SECTOR GAMMA AS | 589,311 | $9,488,000 | 1.38% |
BRIDGER MANAGEMENT, LLC | 1,341,143 | $21,592,000 | 1.23% |
Eos Focused Equity Management, L.P. | 48,714 | $784,000 | 0.89% |
Bridge City Capital, LLC | 47,194 | $760,000 | 0.64% |
Fosun International Ltd | 300,000 | $4,830,000 | 0.60% |
Century Capital Management, LLC | 203,138 | $3,271,000 | 0.56% |